Company La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
Business Summary
Number of employees: 61
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Hearne
DFI | Director of Finance/CFO | 61 | 01/20/01 |
Tony Hodges
CTO | Chief Tech/Sci/R&D Officer | - | 12/21/12 |
Luke Seikkula
COO | Chief Operating Officer | 60 | 01/19/01 |
Paula Rusu
PRN | Corporate Officer/Principal | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marianne Zhen
BRD | Director/Board Member | 55 | 22/22/22 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 22/22/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,936,883 | 24,826,697 ( 99.56 %) | 0 | 99.54 % |
Stock B | 0 | 3,907 | 0 | 0 |
Company contact information
La Jolla Pharmaceutical Co.
201 Jones Road Suite 400
02451, Waltham
+617 715 3600
https://www.lajollapharmaceutical.com![address La Jolla Pharmaceutical Company(LJPC)](https://cdn.zonebourse.com/static/address/23894309.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.45% | 12TCr | |
+21.96% | 12TCr | |
+23.73% | 2.7TCr | |
-20.05% | 2.04TCr | |
-16.28% | 1.59TCr | |
-16.52% | 1.64TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.49TCr | |
+2.52% | 1.36TCr |